Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PerImmune was a private U.S. biopharmaceutical company based in Rockville, Maryland that focused on immunotherapy, cancer vaccines, human monoclonal antibodies, and diagnostic products. Historical reports indicate the company developed products for cancer and infectious disease applications, including a KLH-based bladder cancer immunotherapy program and a physician office-based bladder cancer recurrence test. PerImmune originated from Organon Teknika through a 1996 management buyout and later merged with Intracel in 1998. The company appears to be inactive today as an independent operating business, but it left behind patents and product-development work in oncology immunotherapy and diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PerImmune.